Passage Bio, Inc. (NASDAQ:PASG – Get Rating) has been given an average recommendation of “Buy” by the seven brokerages that are covering the company, MarketBeat Ratings reports. Six research analysts have rated the stock with a buy rating. The average 1-year price target among analysts that have issued ratings on the stock in the last […]
Shares of Passage Bio, Inc. (NASDAQ:PASG – Get Rating) have been given a consensus recommendation of “Buy” by the seven brokerages that are currently covering the company, Marketbeat Ratings reports. Six investment analysts have rated the stock with a buy recommendation. The average 12-month target price among brokers that have issued a report on the […]
Passage Bio, Inc. (NASDAQ:PASG – Get Rating) has been assigned a consensus recommendation of “Buy” from the seven research firms that are currently covering the firm, Marketbeat reports. Six equities research analysts have rated the stock with a buy rating. The average 12 month price target among analysts that have updated their coverage on the […]
Passage Bio, Inc. (NASDAQ:PASG – Get Rating) has been given an average recommendation of “Buy” by the seven ratings firms that are currently covering the firm, Marketbeat reports. Six investment analysts have rated the stock with a buy rating. The average 12-month target price among analysts that have covered the stock in the last year […]
Passage Bio, Inc. (NASDAQ:PASG – Get Rating) has earned a consensus rating of “Buy” from the seven ratings firms that are currently covering the firm, MarketBeat.com reports. Six analysts have rated the stock with a buy recommendation. The average 1 year target price among analysts that have issued ratings on the stock in the last […]